rs200623501
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_016239.4(MYO15A):c.6785G>A(p.Arg2262His) variant causes a missense change. The variant allele was found at a frequency of 0.000284 in 1,601,318 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2262C) has been classified as Uncertain significance.
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYO15A | NM_016239.4 | c.6785G>A | p.Arg2262His | missense_variant | 33/66 | ENST00000647165.2 | |
MYO15A | XM_017024715.3 | c.6788G>A | p.Arg2263His | missense_variant | 31/64 | ||
MYO15A | XM_017024714.3 | c.6725G>A | p.Arg2242His | missense_variant | 30/63 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYO15A | ENST00000647165.2 | c.6785G>A | p.Arg2262His | missense_variant | 33/66 | NM_016239.4 | P1 | ||
MYO15A | ENST00000578999.1 | n.297G>A | non_coding_transcript_exon_variant | 3/4 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.00149 AC: 226AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000315 AC: 71AN: 225674Hom.: 0 AF XY: 0.000236 AC XY: 29AN XY: 122910
GnomAD4 exome AF: 0.000157 AC: 228AN: 1449030Hom.: 2 Cov.: 34 AF XY: 0.000135 AC XY: 97AN XY: 719752
GnomAD4 genome ? AF: 0.00148 AC: 226AN: 152288Hom.: 0 Cov.: 32 AF XY: 0.00136 AC XY: 101AN XY: 74468
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 20, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 24, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 12, 2020 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.6785G>A (p.R2262H) alteration is located in exon 33 (coding exon 32) of the MYO15A gene. This alteration results from a G to A substitution at nucleotide position 6785, causing the arginine (R) at amino acid position 2262 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 05, 2017 | p.Arg2262His in exon 33 of MYO15A: This variant is not expected to have clinical significance because it has been identified in 0.46% (100/21764) of African chr omosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitut e.org; dbSNP rs200623501). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at